---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-22-067870"
form_type: "8-K"
ticker: "REPL"
cik: "0001737953"
company_name: "Replimune Group, Inc."
filed_at: "2022-06-03T23:59:59+00:00"
generated_at: "2026-06-25T04:49:16.797548+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Director Jason Rhodes resigns from Replimune Board to focus on Atlas Venture commitments

## Summary
- Jason Rhodes, partner at Atlas Venture, resigned from Replimune's Board effective May 31, 2022.
- Rhodes served on the Board since 2015, when Atlas led Replimune's Series A financing.
- Resignation not due to any dispute; Rhodes cited growing commitments at Atlas, including new fund launch in March 2022.
- CEO Philip Astley-Sparke thanked Rhodes and Atlas for their capital formation and company-building support.

## SEC filing metadata
- accession: 0001104659-22-067870
- form_type: 8-K
- ticker: REPL
- cik: 0001737953
- company_name: Replimune Group, Inc.
- filed_at: 2022-06-03T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1737953/000110465922067870/0001104659-22-067870-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1737953/000110465922067870/tm2217593d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-22-067870
- JSON: https://secwatch.observer/filing/0001104659-22-067870.json
- Plain text: https://secwatch.observer/filing/0001104659-22-067870.txt

## Key facts
- Executive change
  Jason Rhodes resigned as director at Replimune Group, Inc..
  - Action: resigned
  - Role: director
  source text: On May 31, 2022, Jason Rhodes, a member of the Board of Directors (the “Board”) of Replimune Group, Inc. (the “Company”), notified the Board of his decision to resign as a director of the Company, effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1737953/000110465922067870/0001104659-22-067870-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.